These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1447813)

  • 1. [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
    Hosaka Y
    Nihon Rinsho; 1992 Oct; 50(10):2426-31. PubMed ID: 1447813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of cytofluorometry in bladder tumors].
    Verine JL; Coic H; Bertrand G; Lépinard V; Soret JY
    Ann Urol (Paris); 1986; 20(3):175-85. PubMed ID: 3729300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
    Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
    J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study].
    Xue J
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):650-3, 700. PubMed ID: 2632194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
    Bittard H; Lamy B; Billery C
    J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
    Maier G; Heissler HE; Blech M; Schröter W
    Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance and application of DNA ploidy of bladder cancer cells in studying the malignancy of tumors].
    Cao S
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):143-5. PubMed ID: 2163740
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular genetic methods in the diagnosis of invasive bladder cancer.
    Krause FS; Feil G; Zumbrägel A; Bichler KH
    Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry of transitional cell carcinoma of the urinary bladder: influence of prior local therapy.
    Têtu B; Katz RL; Kalter SP; Von Eschenbach AC; Barlogie B
    Semin Diagn Pathol; 1987 Aug; 4(3):243-50. PubMed ID: 3671911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
    Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y
    Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytofluorimetric evaluation of DNA ploidy in the diagnosis of bladder cancer.
    Armone S; Voce S; dal Pozzo C; Severini G; Montanari F; Monti G; Tavolazzi L
    Arch Esp Urol; 1998 Jun; 51(5):507-10. PubMed ID: 9675952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy analysis of invasive bladder cancer by flow cytometry.
    Badalament RA; Smith JJ; Franklin GL; Drago JR
    In Vivo; 1990; 4(4):269-72. PubMed ID: 2103372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
    Nenning H; Rassler J; Minh DH; Stolzenburg JU
    Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometry in diagnosis and treatment of bladder tumor].
    Sun XJ; Song ZL; Wu DC
    Zhonghua Wai Ke Za Zhi; 1994 Mar; 32(3):178-80. PubMed ID: 7842912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor markers and prognostic parameters in urinary bladder cancer].
    Schneider AW; Huland H
    Urologe A; 1990 Mar; 29(2):71-6. PubMed ID: 2184571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
    Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
    J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.